Difference between revisions of "Coronavirus testing"
(a Japanese research institute has developed a test that takes only half an hour) |
(CDC developed and distributed a faulty test in February) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Coronavirus testing''' is relatively easy, non-invasive, affordable, and yet unavailable in most of the [[United States]] as of March 18, 2019, except to professional athletes, [[Hollywood]] actors and actresses, and high-level politicians. The [[FDA]] and [[CDC]] have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests. | '''Coronavirus testing''' is relatively easy, non-invasive, affordable, and yet unavailable in most of the [[United States]] as of March 18, 2019, except to professional athletes, [[Hollywood]] actors and actresses, and high-level politicians. The [[FDA]] and [[CDC]] have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests. | ||
| + | * FDA rules initially prevented state and commercial labs from developing their own coronavirus diagnostic tests ... [https://www.whio.com/news/local/coronavirus-new-cleveland-clinic-testing-capabilities-deliver-results-within-hours/] | ||
Those having early, special access to coronavirus testing include entire [[NBA]] teams and congressmen. | Those having early, special access to coronavirus testing include entire [[NBA]] teams and congressmen. | ||
| Line 9: | Line 10: | ||
The ''Japan Times'' says that a Japanese research institute has developed a test that takes only half an hour: | The ''Japan Times'' says that a Japanese research institute has developed a test that takes only half an hour: | ||
*the government-affiliated research institute Riken said ... that they have developed a technology that can detect the COVID-19 coronavirus in only 10 to 30 minutes. [https://www.japantimes.co.jp/news/2020/02/27/national/riken-coronavirus-test/#.XnaZAdTQgdV] | *the government-affiliated research institute Riken said ... that they have developed a technology that can detect the COVID-19 coronavirus in only 10 to 30 minutes. [https://www.japantimes.co.jp/news/2020/02/27/national/riken-coronavirus-test/#.XnaZAdTQgdV] | ||
| + | |||
| + | According to ''The Atlantic'', | ||
| + | :... the Centers for Disease Control and Prevention developed and distributed a faulty test in February. Independent labs created alternatives, but were mired in bureaucracy from the FDA.<ref> [https://www.theatlantic.com/health/archive/2020/03/how-will-coronavirus-end/608719/ How the Pandemic Will End]</ref> | ||
| + | |||
| + | ==References== | ||
| + | {{ref}} | ||
{{Coronavirus}} | {{Coronavirus}} | ||
[[category:coronavirus]] | [[category:coronavirus]] | ||
Latest revision as of 15:07, April 3, 2020
Coronavirus testing is relatively easy, non-invasive, affordable, and yet unavailable in most of the United States as of March 18, 2019, except to professional athletes, Hollywood actors and actresses, and high-level politicians. The FDA and CDC have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests.
- FDA rules initially prevented state and commercial labs from developing their own coronavirus diagnostic tests ... [1]
Those having early, special access to coronavirus testing include entire NBA teams and congressmen.
Insurance companies have balked at providing coverage for treatment of coronavirus, which provides a further incentive for tests to be withheld from the general public.
Convenient drive-through testing has been available in South Korea, which has more of a free market in health care, long before the United States.
The Japan Times says that a Japanese research institute has developed a test that takes only half an hour:
- the government-affiliated research institute Riken said ... that they have developed a technology that can detect the COVID-19 coronavirus in only 10 to 30 minutes. [2]
According to The Atlantic,
- ... the Centers for Disease Control and Prevention developed and distributed a faulty test in February. Independent labs created alternatives, but were mired in bureaucracy from the FDA.[1]